{"article_title": "NuVasive soars after predicting 2013, 2014 sales ahead of forecasts", "article_keywords": ["million", "used", "ahead", "soars", "twitter", "predicting", "sales", "forecasts", "tsunami", "treat", "yearregeneron", "thats", "surgeries", "nuvasive"], "article_url": "http://blogs.marketwatch.com/health-exchange/2014/01/15/nuvasive-soars-after-raising-sales-predictions-above-analysts-estimates/", "article_text": "Medical-device maker NuVasive Inc. soared above peers in its sector Wednesday, jumping 9% after the company announced that its sales for 2013 and 2014 should be higher than previously expected.\n\nNuVasive\n\nNuVasive /quotes/zigman/92312/delayed /quotes/nls/nuva NUVA was up $3.02 to $36.80 a share after declaring that 2013 revenue should reach $683 million, up from its previous forecast of $670 million. That\u2019s also more than the $670.6 million average prediction from analysts polled by FactSet.\n\nA manufacturer of instruments used primarily in spinal surgeries, NuVasive now expects 2014 sales of $725 million, more than the $711.7 million FactSet average.\n\nNuVasive also said its 2013 operating margin will exceed its own forecasts, but didn\u2019t give a number.\n\nNuVasive has scheduled its full-year and fourth-quarter earnings report for March 3.\n\nFollow Russ Britt on Twitter @russbrittmktw\n\nFollow Health Exchange on Twitter @MWHealthBlog\n\nMore health-care news from MarketWatch:\n\nIntercept CEO says his drug could treat \u2018next tsunami\u2019 in liver disease\n\nPro-Obamacare stocks up 52% in the last year\n\nRegeneron leads S&P after making presentation at conference", "article_metadata": {"article.created": "2014-01-15T16:12:52-05:00", "application-name": "MarketWatch.com", "twitter": {"domain": "Marketwatch.com", "description": "NuVasive Inc. soars above the medical-device sector as the company says 2013 and 2014 sales should be higher than expected.", "title": "NuVasive soars after raising sales predictions above analyst estimates", "url": "http://blogs.marketwatch.com/health-exchange/2014/01/15/nuvasive-soars-after-raising-sales-predictions-above-analysts-estimates/", "image": {"src": "http://s.wsj.net/public/resources/MWimages/MW-BS642_NuVasi_MG_20140115150549.jpg"}, "site": "MarketWatch", "card": "summary_large_image"}, "article.author": "Russ Britt", "article.section": "Markets", "keywords": "medical devices,NuVasive Inc.,revenue forecasts,spinal surgery instruments,Stock surge", "article.headline": "NuVasive soars after raising sales predictions above analyst estimates", "msapplication-task": "name=SmartMoney;action-uri=http://www.smartmoney.com/;icon-uri=http://www.smartmoney.com/favicon.ico", "news_keywords": "medical devices,NuVasive Inc.,revenue forecasts,spinal surgery instruments,Stock surge", "author": "Russ Britt", "article.page": "Health Exchange Blog", "description": "NuVasive Inc. soars above the medical-device sector as the company says 2013 and 2014 sales should be higher than expected.", "article.published": "2014-01-15T16:12:52-05:00", "ROBOTS": "noarchive, noodp", "msapplication-tooltip": "MarketWatch", "fb": {"url": "http://blogs.marketwatch.com/health-exchange/2014/01/15/nuvasive-soars-after-raising-sales-predictions-above-analysts-estimates/", "app_id": 283204329838}, "article": {"publisher": "https://www.facebook.com/marketwatch", "image_count": 2}, "og": {"site_name": "Marketwatch", "description": "NuVasive Inc. soars above the medical-device sector as the company says 2013 and 2014 sales should be higher than expected.", "title": "NuVasive soars after raising sales predictions above analyst estimates", "url": "http://blogs.marketwatch.com/health-exchange/2014/01/15/nuvasive-soars-after-raising-sales-predictions-above-analysts-estimates/", "image": {"width": 569, "identifier": "http://s.wsj.net/public/resources/MWimages/MW-BS642_NuVasi_MG_20140115150549.jpg", "height": 398}, "type": "article"}, "article.access": "free", "article.type": "Health Exchange", "article.id": "BL-MW243B-1867", "article.updated": "2014-01-15T16:28:16-05:00"}, "_id": "\"57477af46914bd0286fd7c33\"", "article_summary": "A manufacturer of instruments used primarily in spinal surgeries, NuVasive now expects 2014 sales of $725 million, more than the $711.7 million FactSet average.\nNuVasive also said its 2013 operating margin will exceed its own forecasts, but didn\u2019t give a number.\nMedical-device maker NuVasive Inc. soared above peers in its sector Wednesday, jumping 9% after the company announced that its sales for 2013 and 2014 should be higher than previously expected.\nNuVasive has scheduled its full-year and fourth-quarter earnings report for March 3.\nThat\u2019s also more than the $670.6 million average prediction from analysts polled by FactSet."}